U.S. market Closed. Opens in 57 minutes

RGLS | Regulus Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
RevenueN/AN/AN/A10.01M6.83M72.00K72.00K1.19M20.76M7.67M19.57M12.70M13.79M8.60M
Cost of Revenue21.15M122.00K459.00K15.35K12.35KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-21.15M-122.00K-459.00K9.99M6.82M72.00KN/AN/A20.76M7.67M19.57M12.70M13.79M8.60M
Operating Expenses9.96M28.24M27.82M24.16M23.67M46.84M70.20M82.70M75.52M52.58M37.37M25.27M20.93M24.10M
Selling, General & Admin9.96M9.83M10.02M8.81M11.32M12.86M17.01M18.39M19.13M11.53M7.43M4.93MN/AN/A
Research & Development21.15M18.41M17.79M15.35M12.35M33.98M53.19M64.31M56.39M41.05M29.94M20.34M17.29M20.18M
Other Operating Expenses-21.15M-83.00K9.00K-1.57M-1.76M-1.88MN/AN/AN/AN/AN/AN/A3.64M3.92M
Operating Income-31.11M-28.24M-27.82M-14.15M-16.83M-46.76M-70.13M-81.50M-54.76M-44.91M-17.80M-12.57M-7.14M-15.50M
Other Expenses / Income1.07M-83.00K9.00K-1.57M-1.76M-1.88M-1.97M-338.00K-1.01M-11.77M-889.00K-4.84M-259.00K-91.00K
Before Tax Income-30.04M-28.32M-27.81M-15.73M-18.59M-48.65M-72.10M-81.84M-55.77M-56.68M-18.69M-17.42M-7.40M-15.59M
Income Tax Expenses1.00K1.00K1.00K-467.00K1.00K62.00K-197.00K-4.00K-18.00K1.00K-23.00K-10.00K206.00K-30.00K
Net Income-30.04M-28.32M-27.81M-15.26M-18.59M-48.71M-71.91M-81.84M-55.75M-56.68M-18.67M-17.41M-7.60M-15.56M
Interest Expenses604.00K688.00K855.00K1.81M2.13M2.34M2.72M1.18M52.00K39.00K36.00K247.00K388.00K362.00K
Basic Shares Outstanding18.96M15.26M8.57M3.50M1.73M871.86K626.92K4.40M4.28M3.67M3.21M684.38K1.27M21.39K
Diluted Shares Outstanding18.96M15.26M8.57M3.50M1.73M871.86K626.92K4.40M4.28M3.67M3.21M684.38K1.27M21.39K
EBITDA-30.88M-28.24M-27.82M-14.15M-16.83M-46.76M-66.86M-78.38M-54.12M-55.15M-17.30M-16.15M-6.10M-14.73M
EBITDA Margin0.00%0.00%0.00%-141.47%-246.40%-64,948.61%-92,854.17%-6,564.66%-260.72%-719.13%-88.38%-127.20%-44.22%-171.29%
EBIT-29.43M-27.63M-26.95M-13.92M-16.46M-46.30M-69.38M-80.66M-55.71M-56.64M-18.66M-17.17M-7.01M-15.23M
EBIT Margin0.00%0.00%0.00%-139.14%-240.93%-64,311.11%-96,359.72%-6,755.28%-268.38%-738.56%-95.33%-135.20%-50.82%-177.04%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙